Justice Department Urged To Take “Immediate Action” On Marijuana Grow Applications

Generic 2 March 2019 | 0 Comments

The American Psychological Association (APA) is urging US Attorney General William Barr to review more than two-dozen pending applications for federal marijuana grow licenses. In a letter dated Wednesday, February 27, the association urged the Justice Department to “act immediately” on 26 applications pending before federal officials – applications which were initially submitted to the […]

Tagged in , , ,

DEA Report: Marijuana Seizures Fell Nearly 40 Percent in 2017

Generic 23 May 2018 | 0 Comments

Seizures of indoor and outdoor cannabis crops in the United States fell nearly 40 percent between the years 2016 and 2017, according to annual data compiled by the US Drug Enforcement Administration. According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report, the agency and its law enforcement partners confiscated an estimated 3.38 […]

Tagged in , ,

When It Comes To The Issue Of Cannabis And Opioids, The DEA Admits It Knows Nothing

Generic 16 May 2018 | 0 Comments

In testimony before Congress last week, by DEA acting administrator Robert Patterson opined that the medicalization of cannabis is exacerbating opioid abuse. But when prompted to provide evidence in support of the agency’s position, he acknowledged that he could not. Further, he denied being aware of any evidence — including recent, well-publicized studies by the […]

Tagged in , , ,

Ninth Circuit Court Rejects Challenge To DEA’s Classification Of Marijuana Extracts

Generic 3 May 2018 | 0 Comments

A three judge panel for the Ninth Circuit Court of Appeals has denied a petition filed by the Hemp Industries Association challenging the DEA’s authority to establish a new administrative drug code specifically for marijuana extracts. The DEA first announced the proposed rule change in 2011, but did not enact the new policy until January […]

Tagged in , , ,

Legislation Introduced To End The Federal Government’s Marijuana Production Monopoly

Generic 28 April 2018 | 0 Comments

A bipartisan coalition of over two-dozen federal lawmakers, including House Judiciary Chairman Bob Goodlatte (R-VA) and Matt Gaetz (R-FL), are backing newly introduced legislation — The Medical Cannabis Research Act of 2018 — to facilitate federally-approved clinical trials involving cannabis. Passage of this act would end the University of Mississippi’s existing monopoly on the growth […]

Tagged in , , ,